Oncology (all articles)
Surgery for lung cancer: postoperative changes and complications—what the Radiologist needs to know.
19 Aug, 2021 | 08:36h | UTC
Global, regional, and national burden of respiratory tract cancers and associated risk factors from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study.
18 Aug, 2021 | 08:44h | UTC
Commentary on Twitter (thread – click for more)
1. Congrats to Dr Hedyeh Ebrahimi & collaborators on “#Global, #regional, & #national #burden of #respiratorytract #cancers & associated #riskfactors … (204 countries, #1990- #2019, #GBDstudy)” @LancetRespirMed https://t.co/xzfZZHi6Nz
— Simon I. Hay (@simonihay) August 17, 2021
Effect of early palliative care on end-of-life health care costs: a population-based, propensity score–matched cohort study.
18 Aug, 2021 | 08:30h | UTC
Commentary on Twitter
⚕️@oncoalert:
Ultimately you refer to #palliativeCare because it's what's best for patients. For symptom control, decreased anxiety/depression, & for essential #goalsofcare conversations.The fact that early #pallonc care is cost-saving?
Even better. #hpmhttps://t.co/xVkD2FoP17 pic.twitter.com/drhPxHMCSO— Fumiko Ladd Chino, MD (@fumikochino) August 17, 2021
Study finds editorialists in top journals with industry-related conflicts of interest were more likely to author an unduly favorable editorial for cancer drugs.
17 Aug, 2021 | 08:47h | UTC
RCT: New blood test could improve prostate cancer screening.
17 Aug, 2021 | 08:48h | UTCProstate cancer screening using a combination of risk-prediction, MRI, and targeted prostate biopsies (STHLM3-MRI): a prospective, population-based, randomised, open-label, non-inferiority trial – The Lancet Oncology (link to abstract – $ for full-text)
News release: New blood test improves prostate cancer screening – Karolinska Institutet
Related:
RCT: MRI can cut overdiagnoses in prostate-cancer screening by half.
Commentary on Twitter
Online first: #Prostatecancer #screening using a combination of risk-prediction, MRI, and targeted prostate biopsies (STHLM3-MRI): a prospective, population-based, randomised, open-label, non-inferiority trial #pcsm https://t.co/bijoJk8RbK pic.twitter.com/ENWEjqG3Kr
— The Lancet Oncology (@TheLancetOncol) August 13, 2021
Cohort study: Association of incomplete polyp removal with risk of postcolonoscopy colorectal cancer.
17 Aug, 2021 | 08:43h | UTCOriginal study: Recurrence of Colorectal Neoplastic Polyps After Incomplete Resection – Annals of Internal Medicine (link to abstract – $ for full-text)
FDA authorizes additional Covid-19 vaccine dose for certain immunocompromised individuals – Other fully vaccinated individuals do not need an additional vaccine dose right now.
16 Aug, 2021 | 01:22h | UTCCommentaries:
CDC, FDA recommend COVID booster for immune-compromised – CIDRAP
FDA authorizes additional dose of Covid-19 vaccine for the immunocompromised – STAT
Covid booster: US approves third jab for the immunocompromised – BBC
CDC Panel Recommends 3rd Vaccine Dose For Immunocompromised People – NPR
6 Things To Know If You’re Immunocompromised And Considering A 3rd Shot – NPR
CDC recommends third Covid-19 vaccine dose for certain immunocompromised people – CNN
Commentary on Twitter
The Infectious Diseases Society of America (IDSA) supports the @FDA and @CDCgov's decision to authorize a supplemental vaccine dose for immunocompromised patients.
Read our statement: https://t.co/odzzSgIxnY pic.twitter.com/4PZfUwpjhM
— IDSA (@IDSAInfo) August 13, 2021
Guideline: Acute abdomen in the immunocompromised patient.
16 Aug, 2021 | 01:00h | UTC
Randomized phase III trial of prophylactic cranial irradiation with or without hippocampal avoidance for small-cell lung cancer – “This trial provides the first clinical evidence that sparing the hippocampus during PCI in patients with SCLC better preserves cognitive function”.
13 Aug, 2021 | 08:54h | UTC
Global Incidence and Mortality of Gastric Cancer, 1980-2018
13 Aug, 2021 | 08:45h | UTCGlobal Incidence and Mortality of Gastric Cancer, 1980-2018 – JAMA Network Open
ASCO Guideline Update: Chemotherapy and Targeted Therapy for Patients with Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer That is Either Endocrine-Pretreated or Hormone Receptor–Negative.
12 Aug, 2021 | 08:52h | UTC
ESMO Guideline: Cancer cachexia in adult patients.
12 Aug, 2021 | 08:53h | UTC
EANO–ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with brain metastasis from solid tumors.
11 Aug, 2021 | 08:29h | UTCCommentary: New guidelines for the diagnosis and treatment of brain metastases – University of Vienna
Commentary on Twitter
Just out? @EANOassociation-ESMO Guidelines for the management of patients with #brain metastasis from solid #tumours: find out the latest recommendations, immunohistochemical markers for #carcinoma of unknown primary and treatment algorithms ? https://t.co/CriaZKxFJr #btsm pic.twitter.com/0yQqmJMzT1
— ESMO – Eur. Oncology (@myESMO) August 5, 2021
Cystic pancreatic lesions: MR imaging findings and management.
11 Aug, 2021 | 08:21h | UTCCystic pancreatic lesions: MR imaging findings and management – Insights into Imaging
Related:
Recommendations for the management of incidental pancreatic findings in adults.
Pancreatic cystic neoplasms: a review of current recommendations for surveillance and management
Management of Pancreatic Cystic Lesions
Consensus Recommendations: Diagnosis and Surveillance of Incidental Pancreatic Cystic Lesions
Review: Pancreatic Cystic Lesions
Guidelines on pancreatic cystic neoplasms
ASCO Resource-Stratified Guideline: Assessment of adult women with ovarian masses and treatment of epithelial ovarian cancer.
8 Aug, 2021 | 23:38h | UTCCommentary: ASCO Publishes Resource-Stratified Guideline on Assessment and Treatment of Ovarian Cancer – The ASCO Post
Viewpoint: Cancer as a Global Health Priority.
8 Aug, 2021 | 23:37h | UTCCancer as a Global Health Priority – JAMA (free for a limited period)
RCT: Efficacy of concurrent chemoradiotherapy with S-1 vs. radiotherapy alone for older patients with esophageal cancer.
8 Aug, 2021 | 23:35h | UTCEfficacy of Concurrent Chemoradiotherapy With S-1 vs Radiotherapy Alone for Older Patients With Esophageal Cancer: A Multicenter Randomized Phase 3 Clinical Trial – JAMA Oncology (free for a limited period)
Editorial: Primary Chemoradiotherapy for Older Patients With Esophageal Cancer (free for a limited period)
Commentary: Concurrent CRT Effective for Esophageal Cancer in Older Patients — Overall survival at 2 years significantly better versus radiotherapy alone – MedPage Today (free registration required)
Commentary on Twitter
Randomized phase 3 trial of radiation with or w/o S-1 chemo in 298 older pts (median age 77) with esophageal cancer reveals concurrent chemoradiation led to significantly improved progression-free & overall survival https://t.co/wx5FG5VDUH #GICSM pic.twitter.com/SFddL53lCi
— JAMA Oncology (@JAMAOnc) August 6, 2021
The frequency of medical reversals in a cross-sectional analysis of high-impact oncology journals, 2009–2018.
5 Aug, 2021 | 08:37h | UTCRelated:
Review: Medical Reversals in Family Practice
Sham Surgeries: A Tale of Medical Reversals & the Role of the Media
International consensus recommendations on key outcome measures for organ preservation after (chemo) radiotherapy in patients with rectal cancer.
5 Aug, 2021 | 08:38h | UTC
Cancer care in the wake of a cyberattack: how to prepare and what to expect.
5 Aug, 2021 | 08:41h | UTCCancer Care in the Wake of a Cyberattack: How to Prepare and What to Expect – JCO Oncology Practice
Commentary on Twitter
The paper we wish we never had to write based upon our #cyberattack experience at the @UVMcancercenter.
Cancer care in the wake of a cyberattack: How to prepare and what to expect. @UVMMedCenter @UVMLarnerMed #medtwitterhttps://t.co/W3xGcuhZrs pic.twitter.com/cEHYUOt7yU
— Tim Plante, MD MHS (@tbplante) August 4, 2021
Cannabis and Cannabinoid Analgesia position statement – “Due to the lack of high-quality clinical evidence, the IASP does not currently endorse general use of cannabis and cannabinoids for pain relief.”
4 Aug, 2021 | 09:07h | UTCSee also:
Commentary:
More evidence needed to back cannabis as pain treatment, says review – Imperial College London
Medicinal cannabis to manage chronic pain? We don’t have evidence it works – The Conversation
Related:
NICE Guideline: Cannabis-Based Medicinal Products
Short Review: Drug Interactions with Cannabinoids
Meta-Analysis: Cannabinoids Not Effective for Cancer-Related Pain
NCCN Guidelines Insights: Palliative Care.
4 Aug, 2021 | 09:02h | UTC
RCT: First-line nivolumab plus chemotherapy vs. chemotherapy alone for advanced gastric, gastro-esophageal junction, and esophageal adenocarcinoma.
3 Aug, 2021 | 02:02h | UTCFirst-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial – The Lancet (link to abstract – $ for full-text)
Commentary on Twitter (thread – click for more)
#Nivolumab plus chemotherapy shows superior OS, PFS benefit, and acceptable safety profile—compared to chemotherapy alone—in previously untreated advanced gastric, gastro-oesophageal junction, or oesophageal adenocarcinoma.
? https://t.co/0u9R5ZIwd2, by @YJanjigianMD et al.
— The Lancet (@TheLancet) July 8, 2021
Study: many patients with small renal masses can be safely managed with active surveillance.
2 Aug, 2021 | 00:07h | UTCCommentary: More Data Support Active Surveillance for Small Renal Masses — Most patients avoided surgery with no metastasis, better focus on aggressive disease – MedPage Today (free registration required)
Investigation: FDA allows drugs without proven clinical benefit to languish for years on accelerated pathway.
2 Aug, 2021 | 00:09h | UTCNews release: Investigation finds nearly half of drugs granted FDA ‘fast track’ approval lack proven clinical benefit – The BMJ
Commentary: Over 100 Drugs Given Speedy Approvals Still Lack Proof of Clinical Efficacy – MedPage Today (free registration required)